Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein

Richard S. Stewart, Pedro Piccardo, Bernardino Ghetti, David A. Harris

Research output: Contribution to journalArticle

50 Scopus citations

Abstract

Although PrPSc is thought to be the infectious form of the prion protein, it may not be the form that is responsible for neuronal cell death in prion diseases. CtmPrP is a transmembrane version of the prion protein that has been proposed to be a neurotoxic intermediate underlying prion-induced pathogenesis. To investigate this hypothesis, we have constructed transgenic mice that express L9R-3AV PrP, a mutant prion protein that is synthesized exclusively in the CtmPrP form in transfected cells. These mice develop a fatal neurological illness characterized by ataxia and marked neuronal loss in the cerebellum and hippocampus. CtmprP in neurons cultured from transgenic mice is localized to the Golgi apparatus, rather than to the endoplasmic reticulum as in transfected cell lines. Surprisingly, development of the neurodegenerative phenotype is strongly dependent on coexpression of endogenous, wild-type PrP. Our results provide new insights into the cell biology of CtmPrP, the mechanism by which it induces neurodegeneration, and possible cellular activities of PrPC.

Original languageEnglish (US)
Pages (from-to)3469-3477
Number of pages9
JournalJournal of Neuroscience
Volume25
Issue number13
DOIs
StatePublished - Mar 30 2005

Keywords

  • Golgi
  • Mutation
  • Neurodegeneration
  • Prion
  • Transgenic
  • Transmembrane

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein'. Together they form a unique fingerprint.

  • Cite this